We are live on
!
Find out more
N
Nuveen Portfolio holdings
AUM
$369B
1-Year Est. Return
31.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.85%
1 Year Est. Return
+31.66%
3 Year Est. Return
+110.02%
5 Year Est. Return
+148.02%
10 Year Est. Return
+492.84%
AUM
$247B
AUM Growth
-$11.7B
(-4.5%)
Cap. Flow
-$1.08B
Cap. Flow
% of AUM
-0.44%
Top 10 Holdings %
Top 10 Hldgs %
21.96%
Holding
3,327
New
107
Increased
1,095
Reduced
1,938
Closed
58
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alnylam Pharmaceuticals
ALNY
|
+$3.11B |
| 2 |
iShares Russell 1000 Growth ETF
IWF
|
+$300M |
| 3 |
Baxter International
BAX
|
+$237M |
| 4 |
American Tower
AMT
|
+$196M |
| 5 |
UnitedHealth
UNH
|
+$193M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$343M |
| 2 |
Meta Platforms (Facebook)
META
|
+$300M |
| 3 |
Microsoft
MSFT
|
+$294M |
| 4 |
Salesforce
CRM
|
+$266M |
| 5 |
Match Group
MTCH
|
+$248M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.83% |
| 2 | Healthcare | 15.1% |
| 3 | Financials | 12.26% |
| 4 | Consumer Discretionary | 11.08% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Arbor Realty Trust
ABR
$998M
| $6.41M | ﹤0.01% |
557,116
-228,576
| -29% | -$3.36M |
|
1727
Park National Corp
PRK
$3.67B
| $6.41M | ﹤0.01% |
51,470
-943
| -2% | -$122K |
|
1728
10x Genomics
TXG
$6.61B
| $6.4M | ﹤0.01% |
224,871
-9,830
| -4% | -$375K |
|
1729
Amylyx Pharmaceuticals
AMLX
$2.54B
| $6.38M | ﹤0.01% |
356,687
+317,200
| +803% | +$7.91M |
|
1730
PennyMac Financial
PFSI
$4.02B
| $6.36M | ﹤0.01% |
148,162
-8,418
| -5% | -$440K |
|
1731
BancFirst
BANF
$3.8B
| $6.35M | ﹤0.01% |
70,972
+8,412
| +13% | +$862K |
|
|
JBGS
1732
JBG SMITH
JBGS
$708M
| $6.35M | ﹤0.01% |
341,648
-166,488
| -33% | -$3.81M |
|
1733
Kaiser Aluminum
KALU
$3.02B
| $6.35M | ﹤0.01% |
103,463
-892
| -0.9% | -$65.6K |
|
1734
Geron
GERN
$949M
| $6.33M | ﹤0.01% |
1,016,088
+321
| +0% | +$719 |
|
|
RUTH
1735
DELISTED
Ruth's Hospitality Group, Inc.
RUTH
| $6.32M | ﹤0.01% |
374,935
+120,803
| +48% | +$2.14M |
|
1736
Patrick Industries
PATK
$2.85B
| $6.3M | ﹤0.01% |
215,627
+63,924
| +42% | +$2.32M |
|
1737
News Corp Class B
NWS
$17.5B
| $6.28M | ﹤0.01% |
406,905
-8,270
| -2% | -$141K |
|
1738
CareDx
CDNA
$2.42B
| $6.25M | ﹤0.01% |
366,924
+6,729
| +2% | +$144K |
|
1739
Myers Industries
MYE
$1.29B
| $6.24M | ﹤0.01% |
378,799
+13,283
| +4% | +$274K |
|
|
LBAI
1740
DELISTED
Lakeland Bancorp Inc
LBAI
| $6.21M | ﹤0.01% |
387,965
-2,830
| -0.7% | -$45.1K |
|
1741
Howard Hughes
HHH
$4.03B
| $6.21M | ﹤0.01% |
117,621
-15,039
| -11% | -$962K |
|
|
NVRO
1742
DELISTED
NEVRO CORP.
NVRO
| $6.2M | ﹤0.01% |
133,049
-4,086
| -3% | -$190K |
|
1743
Arlo Technologies
ARLO
$1.65B
| $6.19M | ﹤0.01% |
1,334,419
+21,895
| +2% | +$137K |
|
1744
Employers Holdings
EIG
$889M
| $6.19M | ﹤0.01% |
179,405
-2,817
| -2% | -$111K |
|
1745
International Seaways
INSW
$4.57B
| $6.19M | ﹤0.01% |
176,079
-4,344
| -2% | -$120K |
|
1746
Claros Mortgage Trust
CMTG
$274M
| $6.18M | ﹤0.01% |
526,845
+197,461
| +60% | +$3.39M |
|
1747
Newmark Group
NMRK
$2.63B
| $6.18M | ﹤0.01% |
767,033
-606,067
| -44% | -$6.25M |
|
1748
Kodiak Sciences
KOD
$2.84B
| $6.18M | ﹤0.01% |
122,763
-95
| -0.1% | -$923 |
|
|
PLL
1749
DELISTED
Piedmont Lithium
PLL
| $6.17M | ﹤0.01% |
115,255
+56,149
| +95% | +$2.89M |
|
1750
PAR Technology
PAR
$735M
| $6.16M | ﹤0.01% |
208,706
-2,512
| -1% | -$93.2K |
|
Similar funds
VFT
Nuveen's Q3 2022 Portfolio in Review
As of Q3 2022, Nuveen held 3,327 positions worth $247B, down 4.5% from $259B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Trading was light in Q3 2022: portfolio turnover was 5%. Nuveen opened 107 new positions and exited 58, leaving the 3,327-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.
- Nuveen's largest Q3 2022 buy was Alibaba: 1,014,906 shares worth $81.2M.
- Nuveen added most to Alnylam Pharmaceuticals in Q3 2022, an estimated $3.11B increase.
- Nuveen's biggest Q3 2022 reduction was Alphabet (Google) Class A, cutting an estimated $343M.
- Nuveen fully exited Atlassian in Q3 2022, selling an estimated $82.9M.
- Nuveen's ten largest holdings make up 22% of its $247B portfolio in Q3 2022.
- Nuveen opened 107 new positions and closed 58 in Q3 2022.
- Nuveen's portfolio value fell 4.5% quarter-over-quarter to $247B.
Based on Nuveen's 13F filing for Q3 2022, filed 14 Nov 2022.